Next Generation Sequencing Market size was valued at USD 15.4 Billion in 2024 and is forecasted to grow at a CAGR of 9.8% from 2026 to 2033, reaching USD 35.8 Billion by 2033.
South Korea's Next Generation Sequencing Market is experiencing a transformative boom, with projections indicating a surge from $0.2 billion in 2023 to $1.2 billion by 2033, reflecting a robust CAGR of 19.9%. This growth is propelled by the nation's commitment to precision medicine, particularly in oncology and rare disease diagnostics.
Key industry demands are shaping the market's trajectory:
Consumables: Dominating the market due to their recurring nature, essential for ongoing sequencing experiments.
Services: Witnessing rapid growth, especially in human genome sequencing services, expected to reach $948.2 million by 2030.
Technology: Advancements in sequencing platforms and analytical software are reducing costs and improving accessibility.
Industries driving these demands include:
Healthcare: Leveraging NGS for early cancer detection, targeted therapies, and real-time treatment monitoring.
Biopharmaceuticals: Utilizing NGS for biomarker discovery and pharmacogenomics to develop tailored therapeutic solutions.
Research Institutions: Engaging in partnerships and initiatives to establish genomic databases, enhancing drug discovery and treatment modalities.
Despite challenges such as high costs and regulatory concerns surrounding data privacy, South Korea's advanced healthcare infrastructure and government initiatives are fostering an environment conducive to NGS adoption. The nation's focus on personalized healthcare and investment in genomic research positions it as a leading market in the Asia-Pacific region for NGS applications across clinical and research domains.
As someone deeply involved in the biotech sector, I've observed firsthand the rapid integration of NGS technologies in various industries. The collaboration between academic institutions, biotechnology companies, and government bodies is not only accelerating research but also translating into tangible healthcare solutions. The emphasis on precision medicine is reshaping the landscape, making South Korea a pivotal player in the global NGS market.
Get an In-Depth Research Analysis of the South Korea Next Generation Sequencing Market Size And Forecast [2025-2032]
Â
454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters
Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Next Generation Sequencing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Next Generation Sequencing Market
Illumina Sequencing
Ion Torrent Sequencing
PacBio Sequencing
Oxford Nanopore Sequencing
Other Sequencing Technologies
Clinical Applications
Oncology
Infectious Diseases
Genetic Disorders
Personalized Medicine
Pre-sequencing
Sequencing
Data Analysis
Post-sequencing
Sequencing Platforms
Consumables
Software
Reagents
Hospitals and Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Next Generation Sequencing Market Research Analysis
1. Introduction of the South Korea Next Generation Sequencing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Next Generation Sequencing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Next Generation Sequencing Market, By Type
6. South Korea Next Generation Sequencing Market, By Application
7. South Korea Next Generation Sequencing Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Next Generation Sequencing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/